A detailed history of Vontobel Holding Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vontobel Holding Ltd. holds 86,174 shares of LLY stock, worth $68.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
86,174
Previous 105,485 18.31%
Holding current value
$68.6 Million
Previous $95.5 Million 20.06%
% of portfolio
0.26%
Previous 0.32%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $14.9 Million - $18.5 Million
-19,311 Reduced 18.31%
86,174 $76.3 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $14.3 Million - $17.9 Million
-19,689 Reduced 15.73%
105,485 $95.5 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $25.7 Million - $34.3 Million
-43,347 Reduced 25.72%
125,174 $97.4 Million
Q4 2023

Jun 03, 2024

SELL
$525.19 - $619.13 $758,374 - $894,023
-1,444 Reduced 1.23%
115,573 $67.4 Million
Q4 2023

Jan 29, 2024

SELL
$525.19 - $619.13 $1.76 Million - $2.08 Million
-3,353 Reduced 1.95%
168,521 $98.2 Million
Q3 2023

Jun 03, 2024

SELL
$434.7 - $599.3 $4.76 Million - $6.57 Million
-10,961 Reduced 8.56%
117,017 $62.9 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $6.95 Million - $9.58 Million
-15,993 Reduced 8.51%
171,874 $92.3 Million
Q2 2023

Jun 03, 2024

SELL
$350.74 - $468.98 $5.39 Million - $7.21 Million
-15,365 Reduced 10.72%
127,978 $60 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $10.1 Million - $13.5 Million
-28,871 Reduced 13.32%
187,867 $88.1 Million
Q1 2023

Jun 03, 2024

BUY
$310.63 - $364.82 $5.64 Million - $6.63 Million
18,169 Added 14.51%
143,343 $49.2 Million
Q1 2023

Apr 12, 2023

BUY
$310.63 - $364.82 $28 Million - $32.9 Million
90,099 Added 71.15%
216,738 $74.4 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $435,057 - $506,928
-1,353 Reduced 1.06%
126,639 $46.3 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $7.54 Million - $8.59 Million
25,431 Added 24.8%
127,992 $41.4 Million
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $3.42 Million - $4.02 Million
12,286 Added 13.61%
102,561 $33.1 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $2.41 Million - $2.99 Million
-10,250 Reduced 10.2%
90,275 $26.2 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $7.93 Million - $9.84 Million
35,276 Added 54.06%
100,525 $27.9 Million
Q3 2021

Oct 29, 2021

BUY
$221.6 - $272.71 $255,726 - $314,707
1,154 Added 1.8%
65,249 $15.1 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $1.74 Million - $2.25 Million
-9,630 Reduced 13.06%
64,095 $14.7 Million
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $522,373 - $676,236
-3,179 Reduced 4.13%
73,725 $13.8 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $10 Million - $13.3 Million
76,904 New
76,904 $15.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.